The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
Open accessAbstract
PTEN (phosphatase and tensin homolog deleted on chromosome ten) is a lipid phosphatase that counteracts the function of phosphatidylinositol-3 kinase (PI3K). Loss of function of PTEN results in constitutive activation of AKT and downstream effectors and correlates with many human cancers, as well as various brain disorders, including macrocephaly, seizures, Lhermitte–Duclos disease, and autism. We previously generated a conditional Pten knock-out mouse line with Pten loss in limited postmitotic neurons in the cortex and hippocampus.Pten-null neurons developed neuronal hypertrophy and loss of neuronal polarity. The mutant mice exhibited macrocephaly and behavioral abnormalities reminiscent of certain features of human autism. Here, we report that rapamycin, a specific inhibitor of mammalian target of rapamycin complex 1 (mTORC1), can prevent and reverse neuronal hypertrophy, resulting in the amelioration of a subset of PTEN-associated abnormal behaviors, providing evidence that the mTORC1 pathway downstream of PTEN is critical for this complex phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally in animal models of autism spectrum disorder (ASD), altered mTORC1 signaling contributes to the observed synaptic dysfunction and aberrant network connectivity (13,15,(21)(22)(23)(24)(25)(26)(27).”
From Analysis of proteins that rapidly change upon mechanistic/mammalian target of rapamycin complex 1 (mTORC1) repression identifies parkinson protein 7 (PARK7) as a novel protein aberrantly expressed in tuberous sclerosis complex (TSC) (2016) · cites this paper as [21]
Experimental — accuracy not yet measuredIn the citing paper
“Notably, pharmacological and genetic manipulations have successfully rescued both structural and behavioral phenotypes in PTEN86, FMR1 (ref. 87) and MECP2 (ref. 88) knockout mice.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“That behavioral recovery in each of these rescue strategies was paralleled by reversal of spine pathologies underscores the importance of these structural perturbations in the pathogenesis of ASDs and comorbid disorders and the potential for the use of animal models in the development of therapeutics.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [86]
In the citing paper
“Rapamycin successfully reduced cognitive impairment and social behavior deficit in mouse models of tuberous sclerosis 61-63 and improved behavior in adult mice with a deletion of PTEN 64 .”
From Progress toward treatments for synaptic defects in autism (2013) · cites this paper as [64]
In the citing paper
“Experimental interventions, working through diverse genetic and pharmacological mechanisms, rescue subsets of behavioral abnormalities in these mouse models (31, 43, 48–52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
In the citing paper
“Target strategies draw from therapeutics under investigation for other neurodevelopmental disorders and hypotheses emerging from mutations in synaptic genes identified in small numbers of individuals with autism spectrum disorders (43, 49, 52).”
From Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism (2012) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Self-citationTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast
Heitman, J., Movva, N. R., & Hall, M. N. (1991) · Science · doi:10.1126/science.1715094 · Cited by 2,010
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Self-citationAkt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882
Cited by
Sorted by citations
Items 301–400 of 441
Lin, Y., Lin, K., Kang, D., Liu, X., Wang, X., Zheng, S., Yu, L., & Lin, Z. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.02.002 · Cited by 12
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy
Jeong, A., & Wong, M. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1151788 · Cited by 12
MTOR pathway in focal cortical dysplasia type 2: What do we know?
Majolo, F., Marinowic, D. R., Machado, D. C., & da Costa, J. C. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.014 · Cited by 12
Jiang, J., Zhang, L., Zou, J., Liu, J., Yang, J., Jiang, Q., Duan, P., & Jiang, B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371372 · Cited by 11
Narvaiz, D. A., Nolan, S. O., Smith, G. D., Holley, A. J., Reynolds, C. D., Blandin, K. J., Nguyen, P. H., Tran, D. L. K., & Lugo, J. N. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12854 · Cited by 9
Kusne, Y. N., Goldberg, E. L., Parker, S. S., Hapak, S. M., Maskaykina, I. Y., Chew, W. M., Limesand, K. H., Brooks, H. L., Price, T. J., Sanai, N., et al. (2013) · AGE · doi:10.1007/s11357-013-9572-5 · Cited by 11
Mouse Behavior and Models for Autism Spectrum Disorders
Ricceri, L., Michetti, C., & Scattoni, M. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00017-0 · Cited by 13
mTOR Signaling in Epilepsy and Epileptogenesis
Leo, A., Constanti, A., Coppola, A., Citraro, R., Sarro, G. D., & Russo, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00006-2 · Cited by 11
Marinowic, D. R., Majolo, F., Zanirati, G., Plentz, I., Neto, E. P., Palmini, A., Machado, D. C., & da Costa, J. C. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.11.016 · Cited by 11
Kwak, S. S., Jeong, M., Choi, J. H., Kim, D., Min, H., Yoon, Y., Hwang, O., Meadows, G. G., & Joe, C. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060803 · Cited by 11
Activated protein C in epilepsy pathophysiology
Zoungrana, L. I., Didik, S., Wang, H., Slotabec, L. A., & Li, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1251017 · Cited by 11
Zhang, L., Lai, C., Yanhong, S., Huizhong, G., Li, Y., Zhen, Y., Shan, X., Gong, F., Lv, Y., Li, J., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4093138 · Cited by 10
Silva, A. L. T. E., Glaser, T., Griesi‐Oliveira, K., Corrêa-Velloso, J. C., Wang, J. Y. T., Campos, G. D. S., Ulrich, H., Balan, A., Zarrei, M., Higginbotham, E. J., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01997-9 · Cited by 11
de Abreu, M. S., Demin, K. A., Kotova, M. M., Mirzaei, F., Shariff, S., Kantawala, B., Zakharchenko, K. V., Kolesnikova, T. O., Dilbaryan, K., Grigoryan, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021530 · Cited by 10
CHI, O. Z., Wu, C., Liu, X., Rah, K. H., Jacinto, E., & Weiss, H. R. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8359-5 · Cited by 11
Impact of Oxidative Stress on Development
Wells, P. G., Miller‐Pinsler, L., & Shapiro, A. M. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4939-1405-0_1 · Cited by 10
Reynolds, J. R., Jimenez-Mateos, E. M., Cao, L., Bian, F., Alves, M., Miller-Delaney, S. F. C., Zhou, A., & Henshall, D. C. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2260-6 · Cited by 12
Mirzaa, G., Ashwal, S., & Dobyns, W. B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00025-1 · Cited by 10
Михалкин, А. А., & Merkulyeva, N. S. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021050021 · Cited by 9
Huang, W., Chen, Y., & Page, D. T. (2019) · Autism Research · doi:10.1002/aur.2186 · Cited by 11
Ko, A., Sim, N. S., Choi, H. S., Yang, D., Kim, S. H., Lee, J. S., Kim, D.-S., Lee, J. H., Kim, H. D., & Kang, H. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.1.71 · Cited by 9
Tuberous sclerosis complex: everything old is new again
Ess, K. C. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9014-y · Cited by 9
Aronica, E., Mühlebner, A., van Vliet, E. A., & Gorter, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00011-0 · Cited by 9
Persico, A. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00045-5 · Cited by 9
Cheung, S. K. K., Kwok, J., Or, P. M. Y., Wong, C. W., Feng, B., Choy, K. W., Chang, R. C., Burbach, J. P. H., Cheng, A. S. L., & Chan, A. M.-L. (2023) · Scientific Reports · doi:10.1038/s41598-023-33869-7 · Cited by 9
Yonan, J. M., & Steward, O. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106190 · Cited by 8
Therapeutic Targeting of mTORC2 in mTORopathies
Dentel, B., Escamilla, C. O., & Tsai, P. T. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.026 · Cited by 7
Autophagy in Neurodevelopmental Disorders
Lv, M., & Ma, Q. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4272-5_11 · Cited by 7
Zhang, F., Xu, W., Tang, Q., & Huang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-15921-w · Cited by 7
Marinowic, D. R., Pazzin, D. B., de Azevedo, S. P. D. C., Pinzetta, G., de Souza, J. V. M., Schneider, F. T., Previato, T. T. R., Varella, F. J., & da Costa, J. C. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109565 · Cited by 6
Doszyn, O., Kedra, M., & Zmorzyńska, J. (2024) · iScience · doi:10.1016/j.isci.2024.110149 · Cited by 6
Deletion of Arrb2 Down-regulates Autophagy in the Mouse Hippocampus via Akt-mTOR Pathway Activation
Peng, Q., Liu, Y., Yu, L., Shen, Y., Li, F., Feng, S., & Chen, F. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.01.024 · Cited by 6
Mirzaa, G., & Dobyns, W. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00028-x · Cited by 6
Data highlighting the expression of two miR-132/212 target genes—Sirt1 and Pten—after chronic stress
Aten, S., Page, C. E., Kalidindi, A., Wheaton, K. L., Niraula, A., Godbout, J. P., Hoyt, K. R., & Obrietan, K. H. (2018) · Data in Brief · doi:10.1016/j.dib.2018.11.042 · Cited by 6
Nguyen, L. H., Xu, Y., Nair, M., & Bordey, A. (2024) · eLife · doi:10.7554/elife.91010.3 · Cited by 5
Ugale, A. S., Shunmugam, D., Pimpale, L. G., Rebhan, E.-M., & Baccarini, M. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202310137 · Cited by 5
Genetyczne czynniki etiologiczne w zaburzeniach ze spektrum autyzmu (ASD)
Trambacz-Oleszak, S., & Nosulia, T. (2021) · Postępy Biochemii · doi:10.18388/pb.2021_377 · Cited by 5
Young, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801732-6.00025-2 · Cited by 5
Holford, T. W., Letourneau, K. N., Von-Walter, C., Moncaleano, D., Loomis, C. L., & Bolton, M. M. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1597131 · Cited by 5
Tibarewal, P., Rathbone, V., Conduit, S. E., Classen, G. A. E., Black, F., Danesh, M. A., Constantinou, G., Asgarian, Z., Tohyama, K., Kriplani, N., et al. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052527 · Cited by 4
Berg, E. L., & Silverman, J. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816393-1.00010-5 · Cited by 4
Autism risk gene Cul3 alters neuronal morphology via caspase-3 activity in mouse hippocampal neurons
Xia, Q., Singh, A., Wang, J., Xuan, Z., Singer, J. D., & Powell, C. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1320784 · Cited by 4
Self-citationNeuroinflammation and autism: what have we learned so far?
Aytulun, A., & Ünal, D. (2024) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2024.2366722 · Cited by 5
Translational Dysregulation in Autism
Man, H. (2014) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000e124 · Cited by 4
Roberts, T. P. L., Gandal, M. J., Siegel, S. J., Rodrigues, P. V., & Welsh, J. P. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.017 · Cited by 5
The molecular basis of cognitive deficits in pervasive developmental disorders: Table 1.Preprint
Bhattacharya, A., & Klann, E. (2012) · Learning & Memory · doi:10.1101/lm.025007.111 · Cited by 4
Nguyen, L. H., Xu, Y., Nair, M., & Bordey, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.11.553034 · Cited by 4
Somatic mosaicism and interneuron involvement in mTORopathies
Jerow, L. G., Krueger, D. A., Groß, C., & Danzer, S. C. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.02.009 · Cited by 5
Eissa, N., Jayaprakash, P., Aljneibi, S., Alsaadi, A., Alzaabi, S., Łażewska, D., Karcz, T. P., Kieć‐Kononowicz, K., & Sadek, B. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177481 · Cited by 3
The Economic Impact of Medication-Resistant Epilepsy
Begley, C. E., & Jeong, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.004 · Cited by 3
Lawson, R. J., Lipovsek, N. J., Brown, S. P., Jena, A. K., Osko, J. J., & Ransdell, J. L. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1474066 · Cited by 4
Turkalj, L., Mehta, M., Matteson, P. G., Prem, S., Williams, M., Connacher, R., DiCicco-Bloom, E. M., & Millonig, J. H. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_4 · Cited by 3
mTOR signaling in proteostasis and its relevance to autism spectrum disorders
Faus-Garriga, J., 1 Departament de Ciències Experimentals i de la Salut, U. P. F., Novoa, I., & Ozaita, A. (2017) · AIMS Biophysics · doi:10.3934/biophy.2017.1.63 · Cited by 3
Tuberous Sclerosis and Other mTORopathies
Jeong, A., & Wong, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00054-7 · Cited by 3
From bedside to bench and back: Translating ASD models
Drozd, H. P., Karathanasis, S. F., Molosh, A. I., Lukkes, J. L., Clapp, D. W., & Shekhar, A. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.10.003 · Cited by 3
Dendritic spine pathology in neuropsychiatric
Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2011) · Cited by 2
Kowalczyk, M., Lee, Y., & Huang, W. (2024) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-08-0366 · Cited by 2
Bilal, F., Soueid, J., Saab, S., Makhoul, N. J., Hamzé, Z., El-Bazzal, L., Makoukji, J., & Boustany, R. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.06.005 · Cited by 2
Zhang, Z., Keyser, C., Li, Y., Rosolia, B. J., Porch, M. W., Zhang, W., Su, B., Peng, J. C., Zukin, R. S., & Yan, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03207-6 · Cited by 3
Self-citationMedication-Resistant Epilepsy in Adults
Holtkamp, M., & Benninger, F. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.014 · Cited by 2
Sosunov, A. A., McKhann, G. M., Tang, G., & Goldman, J. E. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae079 · Cited by 2
Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder
Schroeder, J. C., Deliu, E., Novarino, G., & Schmeißer, M. J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_10 · Cited by 2
Pharmacotherapy for Medication-Resistant Epilepsy
Powell, G. A., & Marson, A. G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.016 · Cited by 2
Emerging Research towards the Understanding and Treatment of Autism
Wang, P. P., Hammond, R., Postma, F. R., & Healy, A. M. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734943-00384 · Cited by 1
Psychiatric Comorbidities in Medication-Resistant Epilepsy
Kanner, A. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.023 · Cited by 1
Medication-Resistant Epilepsy Syndromes in Children
Pestana‐Knight, E., & Wyllie, E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.013 · Cited by 1
The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder
Bonetti, M., Borsani, E., & Bonomini, F. (2024) · Cells · doi:10.3390/cells13242036 · Cited by 1
Hauptman, J. S., Antonios, J. P., Mathern, G. W., Levine, M., & Cepeda, C. (2025) · Cells · doi:10.3390/cells14020079 · Cited by 1
Beina, S., Yu, G., Huang, N.-X., & Xiao, L. (2025) · Advances in neurobiology · doi:10.1007/978-3-031-87919-7_15 · Cited by 1
miR-199a functions downstream of MeCP2 in neurons of MECP2 duplication syndrome models
Akaba, Y., Takahashi, S., Adachi, S., Nishimura, M., Suzuki, K., Nakashima, H., Nakashima, K., Kira, R., Chong, P. F., Sakai, Y., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113789 · Cited by 1
Focal postnatal deletion of Tsc2 causes epilepsy
McCoy, C., Dusing, M. R., Jerow, L. G., Winstel, G. C., Zhan, F., Rogers, J. L., Wesley, M., Otten, J. B., Danzer, S. C., & LaSarge, C. L. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1686023 · Cited by 1
Retrograde control of sympathetic neuron-satellite glia interactions by target-derived NGF signaling
Kumari, R., Boehm, E. D., Paşcalău, R., Pfeiffer, R. L., Jones, B. W., Tampakakis, E., & Kuruvilla, R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116697 · Cited by 1
mRNA Translation and Proteasomal Degradation in Health and Neurological Disease
Isaac, A. R., Cozachenco, D., Wagner, B. D. A., Chauvet, M. G., & Lourenco, M. V. (2026) · Physiology · doi:10.1152/physiol.00023.2025 · Cited by 1
Tong, B., Song, Y., Li, Z., Cai, M., Qi, H., Su, K., & Xu, H. A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01599 · Cited by 1
Translational Control of Synaptic Plasticity and Memory
Khoutorsky, A., Gkogkas, C. G., & Sonenberg, N. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3991-2_14 · Cited by 1
Ren, K., Chen, L., Sheng, G., Wang, J., Jin, X., & Jiang, K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.11.039 · Cited by 1
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
Kresak, J. L., Roper, S. N., & Yachnis, A. T. (2013) · Pathology Case Reviews · doi:10.1097/pcr.0000000000000008 · Cited by 1
Translational Neuroimaging for Drug Discovery and Development in Autism Spectrum Disorders
Badura, L. L., Saxe, M., Risterucci, C., Brammer, M. J., McTighe, S. M., Ring, R. H., & Smith, D. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00009-3 · Cited by 1
Intracellular Pathways Associated with the Etiology of Autism
Russo, A. J. (2017) · InTech eBooks · doi:10.5772/67206
Social Consequences of Medication-Resistant Epilepsy
Crepeau, A. Z., & Sirven, J. I. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.005 · Cited by 1
(2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376 · Cited by 1
Bolivar, V. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.012 · Cited by 1
Jansen, L. A. (2020) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759720905835 · Cited by 1
[Research advances in the role of mTOR signaling pathway in autism spectrum disorder].
Sheng, G., & Jiang, K. (2019) · PubMed Central · doi:10.7499/j.issn.1008-8830.2019.07.019 · Cited by 1
The Natural History of Epilepsy
Lee, B., & Kim, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781316492376.001 · Cited by 1
Belle, J. E. L., Condro, M. C., Cepeda, C., Oikonomou, K. D., Tessema, K. K., Dudley, L., Schoenfield, J., Kawaguchi, R., Geschwind, D. H., Silva, A. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.08.602602 · Cited by 1
Toward Fulfilling the Promise of Molecular Medicine in Fragile X
Krueger‐Burg, D., & Bear, M. F. (2011) · DSpace@MIT (Massachusetts Institute of Technology)
(2015) · Therapeutic Targets for Neurological Diseases · doi:10.14800/ttnd.302
Pathology and treatment of autism spectrum disorders
Kotajima‐Murakami, H., Sato, A., & Ikeda, K. (2015) · Folia Pharmacologica Japonica · doi:10.1254/fpj.145.193
Deleting PTEN for better or worse
Welberg, L. (2009) · Nature reviews. Neuroscience · doi:10.1038/nrn2625
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010
Examination of the role of PTEN in ionotropic glutamate receptor expression
Kazdoba-Leach, T. (2014) · doi:10.7282/t3n014nj
Emerging concepts in therapies for autism spectrum disorder
Absoud, M. (2016) · BJPsych Advances · doi:10.1192/apt.bp.115.015578
Mouse Behavioral Models for Autism Spectrum Disorders
Wetsel, W. C., Moy, S. S., & Jiang, Y.-H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391924-3.00026-0
Mitochondrial DNA Damage in Autism
Rose, S., Wong, S., & Giulivi, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_21 · Cited by 1
Behavioral Phenotyping in Genetic Mouse Models of Autism Spectrum Disorders: A Translational Outlook
Scattoni, M. L., Michetti, C., Caruso, A., & Ricceri, L. (2017) · Wiley eBooks · doi:10.1002/9781118540770.ch11
Regulation of Local Translation, Synaptic Plasticity, and Cognitive Function by CNOT7
McFleder, R. L. (2017) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2km3r
Metadata
- Authors
- Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- The University of Texas at Dallas (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-02-11
- Volume
- 29
- Issue
- 6
- Pages
- 1773-1783
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC3904448
- OpenAlex
- W2017097994
- Cited by
- 441
- References
- 52
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 17 · 2023: 17 · 2022: 19 · 2021: 22 · 2020: 49 · 2019: 16 · 2018: 24 · 2017: 28 · 2016: 22 · 2015: 37 · 2014: 31 · 2013: 32 · 2012: 39
- FWCI
- 12.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- Funders
- Autism Speaks (AS1270, AS2126)
- Simons Foundation
- National Institute of Mental Health (K08MH065975, R01MH081164)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R21HD065290)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Keywords
- PTEN, mTORC1, rapamycin, neuronal hypertrophy, neuronal polarity, macrocephaly, autism-like behavior, postmitotic neurons, PI3K/Akt signaling, Lhermitte-Duclos disease, seizures, hippocampus, cortex
- MeSH terms
- Animals, Autistic Disorder, Female, Male, Mice, Inbred C57BL, Neurons, Transcription Factors, Mice, Knockout, Sirolimus, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
